MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors

NCT00004886 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: docetaxel
DRUG: dofequidar fumarate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC